rs16957702

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000623421.3(PIK3R5):​c.-148C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.284 in 1,612,304 control chromosomes in the GnomAD database, including 68,661 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6332 hom., cov: 33)
Exomes 𝑓: 0.28 ( 62329 hom. )

Consequence

PIK3R5
ENST00000623421.3 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.54

Publications

15 publications found
Variant links:
Genes affected
PIK3R5 (HGNC:30035): (phosphoinositide-3-kinase regulatory subunit 5) Phosphatidylinositol 3-kinases (PI3Ks) phosphorylate the inositol ring of phosphatidylinositol at the 3-prime position, and play important roles in cell growth, proliferation, differentiation, motility, survival and intracellular trafficking. The PI3Ks are divided into three classes: I, II and III, and only the class I PI3Ks are involved in oncogenesis. This gene encodes the 101 kD regulatory subunit of the class I PI3K gamma complex, which is a dimeric enzyme, consisting of a 110 kD catalytic subunit gamma and a regulatory subunit of either 55, 87 or 101 kD. This protein recruits the catalytic subunit from the cytosol to the plasma membrane through high-affinity interaction with G-beta-gamma proteins. Multiple alternatively spliced transcript variants encoding two distinct isoforms have been found. [provided by RefSeq, Oct 2011]
PIK3R5 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 17-8888776-G-A is Benign according to our data. Variant chr17-8888776-G-A is described in ClinVar as Benign. ClinVar VariationId is 129892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.3 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIK3R5NM_001142633.3 linkc.1011C>T p.Asp337Asp synonymous_variant Exon 10 of 19 ENST00000447110.6 NP_001136105.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIK3R5ENST00000447110.6 linkc.1011C>T p.Asp337Asp synonymous_variant Exon 10 of 19 5 NM_001142633.3 ENSP00000392812.1

Frequencies

GnomAD3 genomes
AF:
0.278
AC:
42341
AN:
152092
Hom.:
6315
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.292
Gnomad AMI
AF:
0.453
Gnomad AMR
AF:
0.301
Gnomad ASJ
AF:
0.332
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.156
Gnomad FIN
AF:
0.189
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.303
Gnomad OTH
AF:
0.298
GnomAD2 exomes
AF:
0.246
AC:
60115
AN:
243942
AF XY:
0.244
show subpopulations
Gnomad AFR exome
AF:
0.295
Gnomad AMR exome
AF:
0.243
Gnomad ASJ exome
AF:
0.322
Gnomad EAS exome
AF:
0.000708
Gnomad FIN exome
AF:
0.191
Gnomad NFE exome
AF:
0.308
Gnomad OTH exome
AF:
0.278
GnomAD4 exome
AF:
0.285
AC:
415773
AN:
1460094
Hom.:
62329
Cov.:
39
AF XY:
0.280
AC XY:
203326
AN XY:
726244
show subpopulations
African (AFR)
AF:
0.292
AC:
9758
AN:
33474
American (AMR)
AF:
0.251
AC:
11199
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.320
AC:
8350
AN:
26128
East Asian (EAS)
AF:
0.000655
AC:
26
AN:
39696
South Asian (SAS)
AF:
0.165
AC:
14263
AN:
86238
European-Finnish (FIN)
AF:
0.207
AC:
10796
AN:
52248
Middle Eastern (MID)
AF:
0.250
AC:
1443
AN:
5768
European-Non Finnish (NFE)
AF:
0.309
AC:
343318
AN:
1111472
Other (OTH)
AF:
0.275
AC:
16620
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
16277
32555
48832
65110
81387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11118
22236
33354
44472
55590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.279
AC:
42393
AN:
152210
Hom.:
6332
Cov.:
33
AF XY:
0.268
AC XY:
19955
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.292
AC:
12147
AN:
41532
American (AMR)
AF:
0.301
AC:
4609
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.332
AC:
1153
AN:
3472
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5188
South Asian (SAS)
AF:
0.154
AC:
745
AN:
4834
European-Finnish (FIN)
AF:
0.189
AC:
2005
AN:
10614
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.303
AC:
20600
AN:
67964
Other (OTH)
AF:
0.295
AC:
623
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1532
3065
4597
6130
7662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
422
844
1266
1688
2110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.294
Hom.:
6472
Bravo
AF:
0.288
Asia WGS
AF:
0.0930
AC:
322
AN:
3478
EpiCase
AF:
0.307
EpiControl
AF:
0.310

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ataxia with oculomotor apraxia type 3 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.12
DANN
Benign
0.58
PhyloP100
-3.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16957702; hg19: chr17-8792093; COSMIC: COSV52652198; COSMIC: COSV52652198; API